Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: BIOCRYST PHARMACEUTICALS INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BIOCRYST PHARMACEUTICALS INC since year 2005 are given in the first table. The second table lists detailed insider transactions reported by BIOCRYST PHARMACEUTICALS INC since 2005. The reporting company's ticker symbol is BCRX. The reporting company's CIK number is 882796. The total value of stock buying during this period is $6,982,005. The total value of stock sales is $13,290,655. The total value of stock exercises is $1,644,184.

Figure 1. Monthly insider transaction values at BIOCRYST PHARMACEUTICALS INC (BCRX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $6,583k

    $658k

    $65k

    $6k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at BIOCRYST PHARMACEUTICALS INC (BCRX) in the past 24 months. See table 2 for insider transaction details.

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • $12.00

    $9.00

    $6.00

    $3.00



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for BIOCRYST PHARMACEUTICALS INC (BCRX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-01 4,339 15,195 0 0 0 0
2007-09 0 0 20,000 240,000 20,000 127,500
2007-08 841,438 6,583,651 0 0 0 0
2007-07 5,122 36,134 0 0 0 0
2007-02 0 0 0 0 16,171 72,898
2007-01 1,407 12,162 0 0 0 0
2006-09 0 0 5,600 57,148 5,600 26,096
2006-08 1,285 11,565 0 0 0 0
2006-07 744 7,209 0 0 0 0
2006-05 44,563 316,089 26,243 397,887 0 0
2006-04 0 0 10,000 180,240 10,684 174,950
2006-03 0 0 184,162 3,778,282 198,846 1,193,253
2006-02 0 0 19,200 318,427 6,167 40,363
2006-01 0 0 0 0 1,512 9,124
2005-12 0 0 566,667 8,318,671 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for BIOCRYST PHARMACEUTICALS INC (BCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-31 Stonehouse Jon P (President & CEO) Purchase 3,000 3.50 10,506
2008-01-31 Darwin Michael A (Principal Accounting Officer) Purchase 1,339 3.50 4,689
2007-09-04 Bennett J Claude (Chief Operating Officer) Sale 20,000 12.00 240,000
2007-09-04 Bennett J Claude (Chief Operating Officer) Option Exercise 20,000 6.38 127,500
2007-08-14 Stonehouse Jon P (President & CEO) Purchase 2,650 9.86 26,129
2007-08-13 Stonehouse Jon P (President & CEO) Purchase 7,250 9.87 71,526
2007-08-06 Featheringill William W Purchase 831,538 7.80 6,485,996
2007-07-31 Stonehouse Jon P (CEO) Purchase 2,463 7.06 17,376
2007-07-31 Nugent Jonathan M (VP Corp Communications) Purchase 285 7.06 2,010
2007-07-31 Alexander W James (SR. VP, Chief Medical Officer) Purchase 2,374 7.06 16,748
2007-02-26 Bennett J Claude (President) Option Exercise 16,171 4.51 72,898
2007-01-31 Nugent Jonathan M (VP Corp Communications) Purchase 223 8.64 1,927
2007-01-31 Riggs Randall B (Senior VP Business Development) Purchase 1,184 8.64 10,235
2006-09-01 Nugent Jonathan M (VP Corp Communications) Sale 5,600 10.20 57,148
2006-09-01 Nugent Jonathan M (VP Corp Communications) Option Exercise 5,600 4.66 26,096
2006-08-14 Alexander W James (SR. VP, Chief Medical Officer) Purchase 1,285 9.00 11,565
2006-07-31 Riggs Randall B (Senior VP Business Development) Purchase 744 9.69 7,209
2006-05-10 Bennett J Claude (President) Purchase 6,563 6.50 42,659
2006-05-03 Bennett J Claude (President) Purchase 35,000 6.50 227,500
2006-05-03 Bennett J Claude (President) Sale 26,243 15.16 397,887
2006-05-03 Seidenberg Beth C Purchase 3,000 15.31 45,930
2006-04-03 Bennett J Claude (President) Sale 10,000 18.02 180,240
2006-04-03 Bennett J Claude (President) Option Exercise 10,684 16.38 174,950
2006-03-15 Darwin Michael A (Chief Financial Officer) Sale 22,650 19.21 435,137
2006-03-15 Darwin Michael A (Chief Financial Officer) Option Exercise 22,650 4.12 93,358
2006-03-03 Riggs Randall B (Senior VP Business Development) Sale 1,512 20.39 30,827
2006-03-03 Bennett J Claude (President) Sale 10,000 21.01 210,114
2006-03-03 Bennett J Claude (President) Option Exercise 11,550 16.38 189,131
2006-03-03 Bugg Charles E (Chairman) Sale 100,000 20.68 2,068,136
2006-03-03 Bugg Charles E (Chairman) Option Exercise 109,764 5.53 607,176
2006-02-13 Bennett J Claude (President) Sale 3,000 16.94 50,804
2006-02-13 Bennett J Claude (President) Option Exercise 6,167 6.54 40,363
2006-02-10 Featheringill William W Sale 16,200 16.52 267,623
2006-01-31 Riggs Randall B (Senior VP Business D) Option Exercise 1,512 6.04 9,124
2005-12-02 Gordon Carl L (Director) Sale 566,667 14.68 8,318,671

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of BIOCRYST PHARMACEUTICALS INC (symbol BCRX, CIK number 882796) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.